BioLineRx Ltd. (BLRX) Social Stream



BioLineRx Ltd. (BLRX): $0.66

0.02 (+2.56%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add BLRX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#323 of 362

in industry

BIOLINERX LTD (BLRX) Price Targets From Analysts

Use the tables below to see what analysts covering BIOLINERX LTD think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-18 2 $19 $10 $14.5 $1.5 866.67%
2022-01-31 1 $19 $7.25 $12.083 $1.5 705.53%
2022-05-12 2 $19 $7 $11.083 $1.5 638.87%
2022-08-18 2 $19 $6 $10.75 $1.5 616.67%
2022-09-28 2 $19 $4 $10.083 $1.5 572.2%
2023-06-07 2 $19 $4 $9.666 $1.5 544.4%
2023-09-05 1 $19 $6 $12.5 $1.5 733.33%
2023-09-14 1 $19 $7 $13 $1.5 766.67%
2023-09-15 1 $21 $7 $14 $1.5 833.33%
2023-11-21 1 $21 $7.6 $14.3 $1.5 853.33%

Price Target Last Issued September 15, 2023

The Trend in the Analyst Price Target


BLRX's average price target has moved up $4.63 over the prior 167 days.

BLRX reports an average of 648.49% for its upside potential over the past 35 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-23 2 19 4.0 9.666 0.77 1155.32%
2023-05-24 2 19 4.0 9.666 1.56 519.62%
2023-06-07 2 19 4.0 9.666 1.62 496.67%
2023-09-05 1 19 6.0 12.500 2.45 410.2%
2023-11-21 1 21 7.6 14.300 1.52 840.79%

BLRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 22 months, BLRX's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BLRX as an investment opportunity.

  • In the context of all US stocks, BIOLINERX LTD's number of analysts covering the stock is higher than 16.98% of them.
  • To contextualize these metrics, consider that out of all US stocks, BIOLINERX LTD's upside potential (average analyst target price relative to current price) is higher than 1054.06% of them.
  • In terms of how BIOLINERX LTD fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -873.02% of that group.
  • BLRX has a higher average analyst price target than 238.24% of Healthcare stocks.

In the Pharmaceutical Products industry, GLMD, EDSA, and DARE are the three stocks most similar to BIOLINERX LTD regarding the price target and analyst recommendation information presented here.

What is the outlook for BLRX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!